But I also recognize that they are only able to secure a very small supply of vaccine and there are many
competing priorities,» says Andrew Azman, an epidemiologist at Johns Hopkins Bloomberg School of
Public Health in Baltimore, Maryland, who in the last month has been part of a team advising WHO on how to allocate the cholera vaccine in Yemen.